Apple stock slips in year-end trading as tech drags; what investors watch next

Apple stock slips in year-end trading as tech drags; what investors watch next

NEW YORK, December 31, 2025, 12:07 ET — Regular session Apple shares dipped on Wednesday as investors continued to trim exposure to large technology names into the end of the year. The iPhone maker’s stock was down 0.2% at $272.63, after trading between $271.78 and $273.58. The move mattered because Apple’s enormous weighting in major indexes often makes it a bellwether for shifts in risk appetite on quiet days, when small flows can move prices more than usual. U.S. stocks were modestly lower in holiday-thin trading, extending a late-December drift that has undercut expectations for a “Santa Claus rally,” a
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab A/S shares fell 3.3% to $30.44 in New York after the company dropped further development of acasunlimab, a late-stage cancer drug, following a portfolio review. Genmab said the move does not affect its 2025 guidance and will focus on other pipeline drugs. The company also completed its acquisition of Merus N.V., paying $97 per share in a tender offer. Merus requested Nasdaq delist its stock after the merger.
Tesla stock today slips as TSLA braces for Q4 deliveries after Tesla posts analyst consensus

Tesla stock today slips as TSLA braces for Q4 deliveries after Tesla posts analyst consensus

Tesla shares slipped 0.2% to $453.58 late Wednesday morning as investors awaited the company’s quarterly deliveries report due Friday. Analyst consensus points to a 13% year-on-year drop in fourth-quarter deliveries, with estimates around 432,810 vehicles. South Korea’s L&F sharply reduced its battery-material supply deal with Tesla, citing lower business tied to Tesla’s battery program.
Meta stock today: META slips after Reuters scam-ad “playbook” report as Manus AI deal stays in focus

Meta stock today: META slips after Reuters scam-ad “playbook” report as Manus AI deal stays in focus

Meta shares fell 0.4% to $663 by late morning Wednesday after a Reuters report said internal documents showed the company delayed tougher ad checks to avoid costs. The U.S. Virgin Islands sued Meta, alleging it profited from scam ads and failed to protect children. Investors are also watching Meta’s planned $2–$3 billion acquisition of AI startup Manus.
31 December 2025
Microsoft stock slips in late-morning trade as year-end tech selling weighs on megacaps

Microsoft stock slips in late-morning trade as year-end tech selling weighs on megacaps

Microsoft shares fell 0.5% to $484.89 in late morning trading Wednesday as investors trimmed tech holdings ahead of year-end. Holiday-thin volumes amplified moves in major tech stocks, with Broadcom down 0.7% and Nvidia up 0.7%. Wall Street’s focus remains on the Fed’s Jan. 27-28 meeting and Microsoft’s upcoming earnings, which have not yet been scheduled.
31 December 2025
Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax’s U.S.-listed shares fell 3.8% to $133.04 late Wednesday morning, reversing part of a recent surge driven by takeover speculation and index inclusion. Trading volume reached about 348,000 shares as the stock swung between $132.13 and $140.25. Investors await updates on strategic interest and new data for obefazimod, the company’s lead drug candidate.
Micron stock slips today as China’s CXMT targets $4.2 billion DRAM IPO

Micron stock slips today as China’s CXMT targets $4.2 billion DRAM IPO

Micron Technology shares fell 1.8% to $287.35 in late-morning New York trading Wednesday after a Reuters report highlighted China’s CXMT plans to raise $4.2 billion for DRAM expansion. Micron’s CFO transferred 35,000 shares to an estate-planning trust, according to a recent filing. The company’s Taiwan unit secured a $149.5 million subsidy for memory chip R&D. Chip stocks and U.S. indexes traded slightly lower.
Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq kept trading in Platinum Analytics Cayman Limited (PLTS) halted Wednesday, listing the reason as “not available” as of 10:23 a.m. ET. The exchange had previously halted PLTS in October after an SEC suspension and requested more information from the company. No further details were provided in the latest notice. Separately, a Bengaluru renter’s late-night noise complaint on Reddit sparked debate over shared-living boundaries.
31 December 2025
Why Life360 stock is sliding today as year-end trading hits tech names

Why Life360 stock is sliding today as year-end trading hits tech names

Life360 shares fell 4.4% to $63.79 in morning Nasdaq trading, down $2.94 from Tuesday’s close, with about 108,000 shares changing hands. The drop came as tech stocks extended losses on the final trading day of 2025. Life360 recently raised its full-year revenue outlook and agreed to buy ad-tech firm Nativo for $120 million. The company’s next earnings report is set for Feb. 26.
XPeng stock slides 6% today as Chinese EV shares retreat in thin year-end trade

XPeng stock slides 6% today as Chinese EV shares retreat in thin year-end trade

XPeng’s U.S.-listed shares fell 6% to $19.99 by late morning in New York on Wednesday, while NIO dropped 9.5% and Li Auto slid 4.8%. Traders cited thin year-end liquidity and awaited January delivery data and details on China’s updated EV subsidies. XPeng’s ADRs traded between $19.87 and $20.54, with volume near 3.9 million shares. Broader U.S. stocks also slipped ahead of the New Year’s holiday.
Applied Digital’s ChronoScale plan: Cloud spin-off and Ekso tie-up puts AI GPUs in focus

Applied Digital’s ChronoScale plan: Cloud spin-off and Ekso tie-up puts AI GPUs in focus

Applied Digital will spin out its cloud unit and merge it with Ekso Bionics to form ChronoScale, with Applied owning about 97% of the new company and Ekso shareholders holding about 3%, according to filings. The deal is based on a non-binding term sheet and aims to close in the first half of 2026. Applied Digital shares rose 2.4% after the announcement, while Ekso shares jumped 103%.

Stock Market Today

Go toTop